GG
TENX icon

Gofen & Glossberg’s Tenax Therapeutics TENX Stock Holding History

Gofen & Glossberg’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$424K Hold
2,387
– – 0.01% 373
2022
Q3 		$649K Hold
2,387
– – 0.02% 275
2022
Q2 		$1.15M Hold
2,387
– – 0.03% 226
2022
Q1 		$3.09M Hold
2,387
– – 0.07% 171
2021
Q4 		$3.97M Hold
2,387
– – 0.09% 153
2021
Q3 		$6.76M Buy
+2,387
New +$6.25M 0.16% 125

Other funds holding TENX

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Gofen & Glossberg's TENX Position: Q4 2022 in Review

Gofen & Glossberg held its Tenax Therapeutics (TENX) position steady in Q4 2022 at 2,387 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #373.

Gofen & Glossberg first reported a position in TENX in Q3 2021 and has held it in 6 quarters since. The position peaked at $6.76M in Q3 2021. 14 funds tracked by Wall St. Rank hold TENX as of Q4 2022.

  • Gofen & Glossberg held 2,387 shares of Tenax Therapeutics worth $424K as of Q4 2022.
  • Gofen & Glossberg left its Tenax Therapeutics share count unchanged in Q4 2022.
  • Tenax Therapeutics made up 0.01% of Gofen & Glossberg's portfolio in Q4 2022, its #373 holding.
  • Gofen & Glossberg first reported a position in Tenax Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • Gofen & Glossberg's Tenax Therapeutics position peaked at $6.76M in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.